The University of Minnesota and Gillette Children’s Specialty Healthcare have teamed to create a new pediatric research study in hemiparesis. The purpose of this study is to determine whether non-invasive transcranial magnetic brain stimulation (TMS) combined with constraint-induced therapy (CIT) results in improved hand control and brain activity.
Treatment involves two weeks of wearing a cast on the unaffected arm, as well as alternating days of arm exercises with a therapist and comfortable brain stimulation. Pictures of the brain are taken before and after the treatment using functional Magnetic Resonance Imaging (fMRI) technology.
To be eligible, children with hemiparesis need to be able to move the paretic hand partially, walk short distances, have no indwelling metal or medical devices, be between the ages of 8-16 years old and have had no seizures within the last 2 years. There is no charge for the testing and therapy treatments, nor payment for participation. We will provide free parking or taxi/transportation service.
If interested in learning more please contact our study coordinator, Maureen Boxrud at 612.626.6415.
This study was recently featured in an article in the Star Tribune.
This study is receiving funding support from the National Institutes of Health (NIH), and is approved by the Food and Drug Administration (FDA).
A Note from Dr. Carey:
Thank you for your interest in this exciting research funded as a Challenge Grant by the National Institutes of Health. I invite you and your child to view the video below and click the “Kids’ Corner” tab to learn more. This research has the potential for transforming rehabilitation methods in children with hemiparesis. We appreciate your consideration in participating in this study.
